Intended for healthcare professionals

Treating actinic keratoses with Efudix® cream

Five per cent 5-fluorouracil cream (5-FU); Efudix® (Valeant Pharmaceuticals Ltd, UK) has proven to be an effective treatment for actinic keratoses. The case study described below presents a patient’s unique perspective on the inflammation and redness associated with 5% 5- FU therapy. At the end of therapy, the patient concluded that his skin hadn’t looked so well in years and that, despite the inflammation and redness the therapy was ‘worth it’.
Dermatology in practice 2007; 15(2): 9–10
To continue reading this article, please sign in or register.